α-Galactosidase delivery using 30Kc19-human serum albumin nanoparticles for effective treatment of Fabry disease (Q41991282)

14 October 2017

α-Galactosidase delivery using 30Kc19-human serum albumin nanoparticles for effective treatment of Fabry disease (English)

1 reference

14 October 2017

1 reference

Hong Jai Lee

1

1 reference

14 October 2017

Hee Ho Park

2

1 reference

14 October 2017

Youngsoo Sohn

3

1 reference

14 October 2017

Jina Ryu

4

1 reference

14 October 2017

Ju Hyun Park

5

1 reference

14 October 2017

Won Jong Rhee

6

1 reference

14 October 2017

Tai Hyun Park

7

1 reference

14 October 2017

language of work or name

English

0 references

publication date

29 June 2016

1 reference

Applied Microbiology and Biotechnology

14 October 2017

1 reference

14 October 2017

100

1 reference

14 October 2017

24

1 reference

14 October 2017

10395-10402

1 reference

https://scigraph.springernature.com/pub.10.1007/s00253-016-7689-z

14 October 2017

0 references

cites work

Enhancement of recombinant protein production in Chinese hamster ovary cells through anti-apoptosis engineering using 30Kc6 gene

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Inhibition of human cell apoptosis by silkworm hemolymph

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Beneficial effect of silkworm hemolymph on a CHO cell system: Inhibition of apoptosis and increase of EPO production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Albumin-based nanoparticles as potential controlled release drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Inhibition of apoptosis by recombinant 30K protein originating from silkworm hemolymph

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Inhibition of apoptosis by a Bombyx mori gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

A protein delivery system using 30Kc19 cell-penetrating protein originating from silkworm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Kinetic effect of silkworm hemolymph on the delayed host cell death in an insect cell-baculovirus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Silkworm hemolymph as a potent inhibitor of apoptosis in Sf9 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Silkworm hemolymph inhibits baculovirus-induced insect cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Albumin nanoparticles with predictable size by desolvation procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Enhancement of recombinant human EPO production and sialylation in chinese hamster ovary cells through Bombyx mori 30Kc19 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Crystal structure of the 30 K protein from the silkworm Bombyx mori reveals a new member of the β-trefoil superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-016-7689-Z

10.1007/S00253-016-7689-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

14 October 2017

0 references

1 reference